Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc P Girard

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Bulletin De L'Academie Nationale De Medecine|January 26, 2006
[The quest for an HIV vaccine]Marc P Girard
Comparative Immunology, Microbiology and Infectious Diseases|October 10, 2007
The global eradication of poliomyelitis: progress and problemsMichel Rey, Marc P Girard
Vaccine|September 27, 2005
Human vaccine research and development: an overviewMarie Paule Kieny, Marc P Girard
International Reviews of Immunology|December 10, 2008
HIV/AIDS vaccines: a need for new concepts?Marc P Girard, Geetha P Bansal
Current Opinion in HIV and AIDS|December 14, 2011
HIV vaccine development at the turn of the 21st centuryMarc P Girard, Stanley A Plotkin
Virologie (Montrouge, France)|January 9, 2020
HIV-1 Preventive vaccines: an attainable goal?Marc P Girard, Stéphane Paul, Bernard Verrier
Vaccine|September 13, 2005
A review of vaccine research and development: tuberculosisMarc P Girard, Uli Fruth, Marie-Paule Kieny
Vaccine|March 15, 2006
A review of vaccine research and development: the human immunodeficiency virus (HIV)Marc P Girard, Saladin K Osmanov, Marie Paule Kieny
Vaccine|April 23, 2013
Report of the Cent Gardes HIV Vaccine Conference: The B-cell response to HIV. Part 2: Non-neutralizing antibodies: Fondation Mérieux Conference Center, Veyrier du Lac, France 5-7 November 2012Marc P Girard, Valentina Picot, Christophe Longuet, et al.
Vaccine|July 6, 2015
Report of the 2014 Cent Gardes HIV Vaccine Conference-Part 2: Cell-mediated immunity, mucosal protection, and clinical trials: Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 October, 2014Marc P Girard, Valentina Picot, Christophe Longuet, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Bulletin De L'Academie Nationale De Medecine|January 26, 2006
[The quest for an HIV vaccine]Marc P Girard
Comparative Immunology, Microbiology and Infectious Diseases|October 10, 2007
The global eradication of poliomyelitis: progress and problemsMichel Rey, Marc P Girard
Vaccine|September 27, 2005
Human vaccine research and development: an overviewMarie Paule Kieny, Marc P Girard
International Reviews of Immunology|December 10, 2008
HIV/AIDS vaccines: a need for new concepts?Marc P Girard, Geetha P Bansal
Current Opinion in HIV and AIDS|December 14, 2011
HIV vaccine development at the turn of the 21st centuryMarc P Girard, Stanley A Plotkin
Virologie (Montrouge, France)|January 9, 2020
HIV-1 Preventive vaccines: an attainable goal?Marc P Girard, Stéphane Paul, Bernard Verrier
Vaccine|September 13, 2005
A review of vaccine research and development: tuberculosisMarc P Girard, Uli Fruth, Marie-Paule Kieny
Vaccine|March 15, 2006
A review of vaccine research and development: the human immunodeficiency virus (HIV)Marc P Girard, Saladin K Osmanov, Marie Paule Kieny
Vaccine|April 23, 2013
Report of the Cent Gardes HIV Vaccine Conference: The B-cell response to HIV. Part 2: Non-neutralizing antibodies: Fondation Mérieux Conference Center, Veyrier du Lac, France 5-7 November 2012Marc P Girard, Valentina Picot, Christophe Longuet, et al.
Vaccine|July 6, 2015
Report of the 2014 Cent Gardes HIV Vaccine Conference-Part 2: Cell-mediated immunity, mucosal protection, and clinical trials: Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 October, 2014Marc P Girard, Valentina Picot, Christophe Longuet, et al.
Pageof 3